首页 > 最新文献

Epigenomes最新文献

英文 中文
Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma. 胰腺癌表观遗传学改变的临床应用。
IF 2.5 Q3 GENETICS & HEREDITY Pub Date : 2021-09-27 DOI: 10.3390/epigenomes5040020
Joyce K Thompson, Filip Bednar

Pancreatic cancer is a molecularly heterogeneous disease. Epigenetic changes and epigenetic regulatory mechanisms underlie at least some of this heterogeneity and contribute to the evolution of aggressive tumor biology in patients and the tumor's intrinsic resistance to therapy. Here we review our current understanding of epigenetic dysregulation in pancreatic cancer and how it is contributing to our efforts in early diagnosis, predictive and prognostic biomarker development and new therapeutic approaches in this deadly cancer.

癌症是一种分子异质性疾病。表观遗传学变化和表观遗传学调控机制至少是这种异质性的基础,并有助于患者侵袭性肿瘤生物学的进化和肿瘤对治疗的内在耐药性。在这里,我们回顾了我们目前对癌症表观遗传失调的理解,以及它如何促进我们在这种致命的癌症的早期诊断、预测和预后生物标志物开发以及新的治疗方法方面的努力。
{"title":"Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma.","authors":"Joyce K Thompson,&nbsp;Filip Bednar","doi":"10.3390/epigenomes5040020","DOIUrl":"10.3390/epigenomes5040020","url":null,"abstract":"<p><p>Pancreatic cancer is a molecularly heterogeneous disease. Epigenetic changes and epigenetic regulatory mechanisms underlie at least some of this heterogeneity and contribute to the evolution of aggressive tumor biology in patients and the tumor's intrinsic resistance to therapy. Here we review our current understanding of epigenetic dysregulation in pancreatic cancer and how it is contributing to our efforts in early diagnosis, predictive and prognostic biomarker development and new therapeutic approaches in this deadly cancer.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"5 4","pages":""},"PeriodicalIF":2.5,"publicationDate":"2021-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715475/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39772993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Evolution of CG Methylation Maintenance Machinery in Plants. 植物CG甲基化维持机制的进化。
IF 2.5 Q3 GENETICS & HEREDITY Pub Date : 2021-09-14 DOI: 10.3390/epigenomes5030019
Louis Tirot, Pauline E Jullien, Mathieu Ingouff

Cytosine methylation is an epigenetic mark present in most eukaryotic genomes that contributes to the regulation of gene expression and the maintenance of genome stability. DNA methylation mostly occurs at CG sequences, where it is initially deposited by de novo DNA methyltransferases and propagated by maintenance DNA methyltransferases (DNMT) during DNA replication. In this review, we first summarize the mechanisms maintaining CG methylation in mammals that involve the DNA Methyltransferase 1 (DNMT1) enzyme and its cofactor, UHRF1 (Ubiquitin-like with PHD and RING Finger domain 1). We then discuss the evolutionary conservation and diversification of these two core factors in the plant kingdom and speculate on potential functions of novel homologues typically observed in land plants but not in mammals.

胞嘧啶甲基化是存在于大多数真核生物基因组中的一种表观遗传标记,有助于基因表达的调节和基因组稳定性的维持。DNA甲基化主要发生在CG序列,在DNA复制过程中,DNA甲基化最初由从头DNA甲基转移酶沉积,并通过维持DNA甲基转移酶(DNMT)进行增殖。在这篇综述中,我们首先总结了哺乳动物中DNA甲基转移酶1 (DNMT1)及其辅助因子UHRF1(泛素样带PHD和RING Finger结构域1)维持CG甲基化的机制,然后讨论了这两个核心因子在植物界的进化保护和多样化,并推测了在陆地植物中观察到而在哺乳动物中没有的新同源物的潜在功能。
{"title":"Evolution of CG Methylation Maintenance Machinery in Plants.","authors":"Louis Tirot,&nbsp;Pauline E Jullien,&nbsp;Mathieu Ingouff","doi":"10.3390/epigenomes5030019","DOIUrl":"https://doi.org/10.3390/epigenomes5030019","url":null,"abstract":"<p><p>Cytosine methylation is an epigenetic mark present in most eukaryotic genomes that contributes to the regulation of gene expression and the maintenance of genome stability. DNA methylation mostly occurs at CG sequences, where it is initially deposited by de novo DNA methyltransferases and propagated by maintenance DNA methyltransferases (DNMT) during DNA replication. In this review, we first summarize the mechanisms maintaining CG methylation in mammals that involve the DNA Methyltransferase 1 (DNMT1) enzyme and its cofactor, UHRF1 (Ubiquitin-like with PHD and RING Finger domain 1). We then discuss the evolutionary conservation and diversification of these two core factors in the plant kingdom and speculate on potential functions of novel homologues typically observed in land plants but not in mammals.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"5 3","pages":""},"PeriodicalIF":2.5,"publicationDate":"2021-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594673/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39650236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Epigenetic Analyses of Alcohol Consumption in Combustible and Non-Combustible Nicotine Product Users. 可燃和非可燃尼古丁产品使用者酒精消费的表观遗传分析。
IF 2.5 Q3 GENETICS & HEREDITY Pub Date : 2021-09-01 DOI: 10.3390/epigenomes5030018
Kelsey Dawes, Luke Sampson, Rachel Reimer, Shelly Miller, Robert Philibert, Allan Andersen

Alcohol and tobacco use are highly comorbid and exacerbate the associated morbidity and mortality of either substance alone. However, the relationship of alcohol consumption to the various forms of nicotine-containing products is not well understood. To improve this understanding, we examined the relationship of alcohol consumption to nicotine product use using self-report, cotinine, and two epigenetic biomarkers specific for smoking (cg05575921) and drinking (Alcohol T Scores (ATS)) in n = 424 subjects. Cigarette users had significantly higher ATS values than the other groups (p < 2.2 × 10-16). Using the objective biomarkers, the intensity of nicotine and alcohol consumption was correlated in both the cigarette and smokeless users (R = -0.66, p = 3.1 × 10-14; R2 = 0.61, p = 1.97 × 10-4). Building upon this idea, we used the objective nicotine biomarkers and age to build and test a Balanced Random Forest classification model for heavy alcohol consumption (ATS > 2.35). The model performed well with an AUC of 0.962, 89.3% sensitivity, and 85% specificity. We conclude that those who use non-combustible nicotine products drink significantly less than smokers, and cigarette and smokeless users drink more with heavier nicotine use. These findings further highlight the lack of informativeness of self-reported alcohol consumption and suggest given the public and private health burden of alcoholism, further research into whether using non-combustible nicotine products as a mode of treatment for dual users should be considered.

酒精和烟草的使用是高度合并症,并加剧任何一种物质单独的相关发病率和死亡率。然而,酒精消费与各种形式的含尼古丁产品之间的关系尚不清楚。为了提高这一认识,我们在424名受试者中使用自我报告、可替宁和两种吸烟特异性表观遗传生物标志物(cg05575921)和饮酒特异性表观遗传生物标志物(酒精T评分(ATS))研究了饮酒与尼古丁产品使用的关系。吸烟人群ATS值显著高于其他组(p < 2.2 × 10-16)。利用客观生物标志物,香烟使用者和无烟使用者的尼古丁和酒精消耗强度均存在相关性(R = -0.66, p = 3.1 × 10-14;R2 = 0.61, p = 1.97 × 10-4)。在此基础上,我们使用客观尼古丁生物标志物和年龄建立并测试了重度酒精消费(ATS > 2.35)的平衡随机森林分类模型。该模型的AUC为0.962,灵敏度为89.3%,特异性为85%。我们的结论是,那些使用不可燃尼古丁产品的人比吸烟者喝得少得多,而香烟和无烟产品的使用者随着尼古丁的大量使用而喝得更多。这些发现进一步强调了自我报告酒精消费的信息缺乏,并建议考虑到酗酒对公共和个人的健康负担,应进一步研究是否应考虑使用不燃尼古丁产品作为双重使用者的治疗模式。
{"title":"Epigenetic Analyses of Alcohol Consumption in Combustible and Non-Combustible Nicotine Product Users.","authors":"Kelsey Dawes,&nbsp;Luke Sampson,&nbsp;Rachel Reimer,&nbsp;Shelly Miller,&nbsp;Robert Philibert,&nbsp;Allan Andersen","doi":"10.3390/epigenomes5030018","DOIUrl":"https://doi.org/10.3390/epigenomes5030018","url":null,"abstract":"<p><p>Alcohol and tobacco use are highly comorbid and exacerbate the associated morbidity and mortality of either substance alone. However, the relationship of alcohol consumption to the various forms of nicotine-containing products is not well understood. To improve this understanding, we examined the relationship of alcohol consumption to nicotine product use using self-report, cotinine, and two epigenetic biomarkers specific for smoking (cg05575921) and drinking (Alcohol T Scores (ATS)) in <i>n</i> = 424 subjects. Cigarette users had significantly higher ATS values than the other groups (<i>p</i> < 2.2 × 10<sup>-16</sup>). Using the objective biomarkers, the intensity of nicotine and alcohol consumption was correlated in both the cigarette and smokeless users (<i>R</i> = -0.66, <i>p</i> = 3.1 × 10<sup>-14</sup>; <i>R</i><sup>2</sup> = 0.61, <i>p</i> = 1.97 × 10<sup>-4</sup>). Building upon this idea, we used the objective nicotine biomarkers and age to build and test a Balanced Random Forest classification model for heavy alcohol consumption (ATS > 2.35). The model performed well with an AUC of 0.962, 89.3% sensitivity, and 85% specificity. We conclude that those who use non-combustible nicotine products drink significantly less than smokers, and cigarette and smokeless users drink more with heavier nicotine use. These findings further highlight the lack of informativeness of self-reported alcohol consumption and suggest given the public and private health burden of alcoholism, further research into whether using non-combustible nicotine products as a mode of treatment for dual users should be considered.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"5 3","pages":""},"PeriodicalIF":2.5,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594674/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39650235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Deciphering Plant Chromatin Regulation via CRISPR/dCas9-Based Epigenome Engineering. 基于CRISPR/ dcas9的表观基因组工程解读植物染色质调控
IF 2.5 Q3 GENETICS & HEREDITY Pub Date : 2021-08-24 DOI: 10.3390/epigenomes5030017
Annick Dubois, François Roudier

CRISPR-based epigenome editing uses dCas9 as a platform to recruit transcription or chromatin regulators at chosen loci. Despite recent and ongoing advances, the full potential of these approaches to studying chromatin functions in vivo remains challenging to exploit. In this review we discuss how recent progress in plants and animals provides new routes to investigate the function of chromatin regulators and address the complexity of associated regulations that are often interconnected. While efficient transcriptional engineering methodologies have been developed and can be used as tools to alter the chromatin state of a locus, examples of direct manipulation of chromatin regulators remain scarce in plants. These reports also reveal pitfalls and limitations of epigenome engineering approaches that are nevertheless informative as they are often associated with locus- and context-dependent features, which include DNA accessibility, initial chromatin and transcriptional state or cellular dynamics. Strategies implemented in different organisms to overcome and even take advantage of these limitations are highlighted, which will further improve our ability to establish the causality and hierarchy of chromatin dynamics on genome regulation.

基于crispr的表观基因组编辑使用dCas9作为平台,在选定的位点上招募转录或染色质调节因子。尽管最近和正在进行的进展,这些方法在体内研究染色质功能的全部潜力仍然具有挑战性。在这篇综述中,我们讨论了植物和动物的最新进展如何为研究染色质调节因子的功能和解决通常相互关联的相关调节的复杂性提供了新的途径。虽然有效的转录工程方法已经开发出来,并且可以用作改变基因座染色质状态的工具,但在植物中直接操纵染色质调节因子的例子仍然很少。这些报告还揭示了表观基因组工程方法的缺陷和局限性,尽管如此,表观基因组工程方法仍然具有信息性,因为它们通常与位点和上下文依赖的特征相关,包括DNA可及性、初始染色质和转录状态或细胞动力学。强调了在不同生物体中实施的克服甚至利用这些限制的策略,这将进一步提高我们建立基因组调控的染色质动力学因果关系和层次结构的能力。
{"title":"Deciphering Plant Chromatin Regulation via CRISPR/dCas9-Based Epigenome Engineering.","authors":"Annick Dubois,&nbsp;François Roudier","doi":"10.3390/epigenomes5030017","DOIUrl":"https://doi.org/10.3390/epigenomes5030017","url":null,"abstract":"<p><p>CRISPR-based epigenome editing uses dCas9 as a platform to recruit transcription or chromatin regulators at chosen loci. Despite recent and ongoing advances, the full potential of these approaches to studying chromatin functions in vivo remains challenging to exploit. In this review we discuss how recent progress in plants and animals provides new routes to investigate the function of chromatin regulators and address the complexity of associated regulations that are often interconnected. While efficient transcriptional engineering methodologies have been developed and can be used as tools to alter the chromatin state of a locus, examples of direct manipulation of chromatin regulators remain scarce in plants. These reports also reveal pitfalls and limitations of epigenome engineering approaches that are nevertheless informative as they are often associated with locus- and context-dependent features, which include DNA accessibility, initial chromatin and transcriptional state or cellular dynamics. Strategies implemented in different organisms to overcome and even take advantage of these limitations are highlighted, which will further improve our ability to establish the causality and hierarchy of chromatin dynamics on genome regulation.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"5 3","pages":""},"PeriodicalIF":2.5,"publicationDate":"2021-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594717/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39650233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Can Immune Suppression and Epigenome Regulation in Placenta Offer Novel Insights into Cancer Immune Evasion and Immunotherapy Resistance? 胎盘中的免疫抑制和表观基因组调控能否为癌症免疫逃避和免疫疗法抗性提供新的见解?
IF 2.5 Q3 GENETICS & HEREDITY Pub Date : 2021-07-25 DOI: 10.3390/epigenomes5030016
Sultana Mehbuba Hossain, Chiemi F Lynch-Sutherland, Aniruddha Chatterjee, Erin C Macaulay, Michael R Eccles

Cancer is the second leading cause of mortality and morbidity in the developed world. Cancer progression involves genetic and epigenetic alterations, accompanied by aggressive changes, such as increased immune evasion, onset of metastasis, and drug resistance. Similar to cancer, DNA hypomethylation, immune suppression, and invasive cell behaviours are also observed in the human placenta. Mechanisms that lead to the acquisition of invasive behaviour, immune evasion, and drug and immunotherapy resistance are presently under intense investigations to improve patient outcomes. Here, we review current knowledge regarding the similarities between immune suppression and epigenome regulation, including the expression of repetitive elements (REs), endogenous retroviruses (ERVs) and transposable elements (TEs) in cells of the placenta and in cancer, which are associated with changes in immune regulation and invasiveness. We explore whether immune suppression and epigenome regulation in placenta offers novel insights into immunotherapy resistance in cancer, and we also discuss the implications and the knowledge gaps relevant to these findings, which are rapidly being accrued in these quite disparate research fields. Finally, we discuss potential linkages between TE, ERV and RE activation and expression, regarding mechanisms of immune regulation in placenta and cancer. A greater understanding of the role of immune suppression and associated epigenome regulation in placenta could help to elucidate some comparable mechanisms operating in cancer, and identify potential new therapeutic targets for treating cancer.

在发达国家,癌症是导致死亡和发病的第二大原因。癌症的发展涉及基因和表观遗传学的改变,并伴随着侵袭性的变化,如增加免疫逃避、开始转移和耐药性。与癌症类似,在人类胎盘中也观察到 DNA 低甲基化、免疫抑制和侵袭性细胞行为。为了改善患者的预后,目前正在对导致侵袭行为、免疫逃避以及耐药性和免疫疗法的机制进行深入研究。在此,我们回顾了目前有关免疫抑制和表观基因组调控之间相似性的知识,包括胎盘和癌症细胞中重复元件(RE)、内源性逆转录病毒(ERV)和转座元件(TE)的表达,这些都与免疫调节和侵袭性的变化有关。我们探讨了胎盘中的免疫抑制和表观基因组调控是否为癌症的免疫治疗耐药性提供了新的见解,我们还讨论了与这些发现相关的影响和知识差距,这些发现正在这些完全不同的研究领域中迅速积累。最后,我们就胎盘和癌症中的免疫调节机制讨论了 TE、ERV 和 RE 的激活和表达之间的潜在联系。进一步了解胎盘中免疫抑制和相关表观基因组调控的作用有助于阐明癌症中的一些类似机制,并确定治疗癌症的潜在新靶点。
{"title":"Can Immune Suppression and Epigenome Regulation in Placenta Offer Novel Insights into Cancer Immune Evasion and Immunotherapy Resistance?","authors":"Sultana Mehbuba Hossain, Chiemi F Lynch-Sutherland, Aniruddha Chatterjee, Erin C Macaulay, Michael R Eccles","doi":"10.3390/epigenomes5030016","DOIUrl":"10.3390/epigenomes5030016","url":null,"abstract":"<p><p>Cancer is the second leading cause of mortality and morbidity in the developed world. Cancer progression involves genetic and epigenetic alterations, accompanied by aggressive changes, such as increased immune evasion, onset of metastasis, and drug resistance. Similar to cancer, DNA hypomethylation, immune suppression, and invasive cell behaviours are also observed in the human placenta. Mechanisms that lead to the acquisition of invasive behaviour, immune evasion, and drug and immunotherapy resistance are presently under intense investigations to improve patient outcomes. Here, we review current knowledge regarding the similarities between immune suppression and epigenome regulation, including the expression of repetitive elements (REs), endogenous retroviruses (ERVs) and transposable elements (TEs) in cells of the placenta and in cancer, which are associated with changes in immune regulation and invasiveness. We explore whether immune suppression and epigenome regulation in placenta offers novel insights into immunotherapy resistance in cancer, and we also discuss the implications and the knowledge gaps relevant to these findings, which are rapidly being accrued in these quite disparate research fields. Finally, we discuss potential linkages between TE, ERV and RE activation and expression, regarding mechanisms of immune regulation in placenta and cancer. A greater understanding of the role of immune suppression and associated epigenome regulation in placenta could help to elucidate some comparable mechanisms operating in cancer, and identify potential new therapeutic targets for treating cancer.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"5 3","pages":""},"PeriodicalIF":2.5,"publicationDate":"2021-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594685/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39650234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
H3K4 Methylation in Aging and Metabolism. 衰老和代谢中的H3K4甲基化。
IF 2.5 Q3 GENETICS & HEREDITY Pub Date : 2021-06-18 DOI: 10.3390/epigenomes5020014
Chia-Ling Hsu, Yi-Chen Lo, Cheng-Fu Kao

During the process of aging, extensive epigenetic alterations are made in response to both exogenous and endogenous stimuli. Here, we summarize the current state of knowledge regarding one such alteration, H3K4 methylation (H3K4me), as it relates to aging in different species. We especially highlight emerging evidence that links this modification with metabolic pathways, which may provide a mechanistic link to explain its role in aging. H3K4me is a widely recognized marker of active transcription, and it appears to play an evolutionarily conserved role in determining organism longevity, though its influence is context specific and requires further clarification. Interestingly, the modulation of H3K4me dynamics may occur as a result of nutritional status, such as methionine restriction. Methionine status appears to influence H3K4me via changes in the level of S-adenosyl methionine (SAM, the universal methyl donor) or the regulation of H3K4-modifying enzyme activities. Since methionine restriction is widely known to extend lifespan, the mechanistic link between methionine metabolic flux, the sensing of methionine concentrations and H3K4me status may provide a cogent explanation for several seemingly disparate observations in aging organisms, including age-dependent H3K4me dynamics, gene expression changes, and physiological aberrations. These connections are not yet entirely understood, especially at a molecular level, and will require further elucidation. To conclude, we discuss some potential H3K4me-mediated molecular mechanisms that may link metabolic status to the aging process.

在衰老过程中,对外源和内源性刺激都会产生广泛的表观遗传学改变。在这里,我们总结了目前关于H3K4甲基化(H3K4me)的知识现状,因为它与不同物种的衰老有关。我们特别强调了将这种修饰与代谢途径联系起来的新证据,这可能为解释其在衰老中的作用提供了机制联系。H3K4me是一种被广泛认可的活性转录标记,它似乎在决定生物体寿命方面发挥着进化上保守的作用,尽管它的影响是特定的,需要进一步澄清。有趣的是,H3K4me动力学的调节可能是营养状况的结果,如甲硫氨酸限制。蛋氨酸状态似乎通过S-腺苷甲硫氨酸(SAM,通用甲基供体)水平的变化或H3K4修饰酶活性的调节来影响H3K4me。由于甲硫氨酸限制被广泛认为可以延长寿命,甲硫氨酸代谢通量、甲硫氨酸浓度的传感和H3K4me状态之间的机制联系可能为衰老生物体中几个看似不同的观察结果提供有力的解释,包括年龄依赖性的H3K4me动力学、基因表达变化和生理异常。这些联系尚不完全清楚,尤其是在分子水平上,需要进一步阐明。最后,我们讨论了一些潜在的H3K4me介导的分子机制,这些机制可能将代谢状态与衰老过程联系起来。
{"title":"H3K4 Methylation in Aging and Metabolism.","authors":"Chia-Ling Hsu,&nbsp;Yi-Chen Lo,&nbsp;Cheng-Fu Kao","doi":"10.3390/epigenomes5020014","DOIUrl":"10.3390/epigenomes5020014","url":null,"abstract":"<p><p>During the process of aging, extensive epigenetic alterations are made in response to both exogenous and endogenous stimuli. Here, we summarize the current state of knowledge regarding one such alteration, H3K4 methylation (H3K4me), as it relates to aging in different species. We especially highlight emerging evidence that links this modification with metabolic pathways, which may provide a mechanistic link to explain its role in aging. H3K4me is a widely recognized marker of active transcription, and it appears to play an evolutionarily conserved role in determining organism longevity, though its influence is context specific and requires further clarification. Interestingly, the modulation of H3K4me dynamics may occur as a result of nutritional status, such as methionine restriction. Methionine status appears to influence H3K4me via changes in the level of <i>S</i>-adenosyl methionine (SAM, the universal methyl donor) or the regulation of H3K4-modifying enzyme activities. Since methionine restriction is widely known to extend lifespan, the mechanistic link between methionine metabolic flux, the sensing of methionine concentrations and H3K4me status may provide a cogent explanation for several seemingly disparate observations in aging organisms, including age-dependent H3K4me dynamics, gene expression changes, and physiological aberrations. These connections are not yet entirely understood, especially at a molecular level, and will require further elucidation. To conclude, we discuss some potential H3K4me-mediated molecular mechanisms that may link metabolic status to the aging process.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"5 2","pages":""},"PeriodicalIF":2.5,"publicationDate":"2021-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3390/epigenomes5020014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39650225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
The Contribution of Epigenetic Inheritance Processes on Age-Related Cognitive Decline and Alzheimer's Disease. 表观遗传过程对与年龄相关的认知能力衰退和阿尔茨海默病的影响。
IF 2.5 Q3 GENETICS & HEREDITY Pub Date : 2021-06-18 DOI: 10.3390/epigenomes5020015
Aina Bellver-Sanchis, Mercè Pallàs, Christian Griñán-Ferré

During the last years, epigenetic processes have emerged as important factors for many neurodegenerative diseases, such as Alzheimer's disease (AD). These complex diseases seem to have a heritable component; however, genome-wide association studies failed to identify the genetic loci involved in the etiology. So, how can these changes be transmitted from one generation to the next? Answering this question would allow us to understand how the environment can affect human populations for multiple generations and explain the high prevalence of neurodegenerative diseases, such as AD. This review pays particular attention to the relationship among epigenetics, cognition, and neurodegeneration across generations, deepening the understanding of the relevance of heritability in neurodegenerative diseases. We highlight some recent examples of EI induced by experiences, focusing on their contribution of processes in learning and memory to point out new targets for therapeutic interventions. Here, we first describe the prominent role of epigenetic factors in memory processing. Then, we briefly discuss aspects of EI. Additionally, we summarize evidence of how epigenetic marks inherited by experience and/or environmental stimuli contribute to cognitive status offspring since better knowledge of EI can provide clues in the appearance and development of age-related cognitive decline and AD.

在过去几年中,表观遗传过程已成为导致阿尔茨海默病(AD)等多种神经退行性疾病的重要因素。这些复杂的疾病似乎都有遗传因素;然而,全基因组关联研究却未能确定与病因有关的基因位点。那么,这些变化是如何代代相传的呢?回答了这个问题,我们就能理解环境是如何影响人类多代人的,并解释为什么神经退行性疾病(如注意力缺失症)发病率如此之高。本综述特别关注表观遗传学、认知和神经退行性疾病之间的跨代关系,从而加深对神经退行性疾病遗传性相关性的理解。我们重点介绍了最近一些由经历诱导的表观遗传学的例子,关注它们对学习和记忆过程的贡献,从而指出治疗干预的新目标。在这里,我们首先描述了表观遗传因素在记忆处理过程中的突出作用。然后,我们简要讨论表观遗传因素的各个方面。此外,我们还总结了经验和/或环境刺激所遗传的表观遗传标记如何对后代的认知状况产生影响的证据,因为更好地了解表观遗传因子可以为与年龄相关的认知衰退和注意力缺失症的出现和发展提供线索。
{"title":"The Contribution of Epigenetic Inheritance Processes on Age-Related Cognitive Decline and Alzheimer's Disease.","authors":"Aina Bellver-Sanchis, Mercè Pallàs, Christian Griñán-Ferré","doi":"10.3390/epigenomes5020015","DOIUrl":"10.3390/epigenomes5020015","url":null,"abstract":"<p><p>During the last years, epigenetic processes have emerged as important factors for many neurodegenerative diseases, such as Alzheimer's disease (AD). These complex diseases seem to have a heritable component; however, genome-wide association studies failed to identify the genetic loci involved in the etiology. So, how can these changes be transmitted from one generation to the next? Answering this question would allow us to understand how the environment can affect human populations for multiple generations and explain the high prevalence of neurodegenerative diseases, such as AD. This review pays particular attention to the relationship among epigenetics, cognition, and neurodegeneration across generations, deepening the understanding of the relevance of heritability in neurodegenerative diseases. We highlight some recent examples of EI induced by experiences, focusing on their contribution of processes in learning and memory to point out new targets for therapeutic interventions. Here, we first describe the prominent role of epigenetic factors in memory processing. Then, we briefly discuss aspects of EI. Additionally, we summarize evidence of how epigenetic marks inherited by experience and/or environmental stimuli contribute to cognitive status offspring since better knowledge of EI can provide clues in the appearance and development of age-related cognitive decline and AD.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"5 2","pages":""},"PeriodicalIF":2.5,"publicationDate":"2021-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594669/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39650227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Placenta as a Target of Epigenetic Alterations in Women with Gestational Diabetes Mellitus and Potential Implications for the Offspring. 胎盘作为妊娠期糖尿病妇女表观遗传改变的靶点及其对后代的潜在影响。
IF 2.5 Q3 GENETICS & HEREDITY Pub Date : 2021-05-10 DOI: 10.3390/epigenomes5020013
Dennise Lizárraga, Alejandra García-Gasca

Gestational diabetes mellitus (GDM) is a pregnancy complication first detected in the second or third trimester in women that did not show evident glucose intolerance or diabetes before gestation. In 2019, the International Diabetes Federation reported that 15.8% of live births were affected by hyperglycemia during pregnancy, of which 83.6% were due to gestational diabetes mellitus, 8.5% were due to diabetes first detected in pregnancy, and 7.9% were due to diabetes detected before pregnancy. GDM increases the susceptibility to developing chronic diseases for both the mother and the baby later in life. Under GDM conditions, the intrauterine environment becomes hyperglycemic, while also showing high concentrations of fatty acids and proinflammatory cytokines, producing morphological, structural, and molecular modifications in the placenta, affecting its function; these alterations may predispose the baby to disease in adult life. Molecular alterations include epigenetic mechanisms such as DNA and RNA methylation, chromatin remodeling, histone modifications, and expression of noncoding RNAs (ncRNAs). The placenta is a unique organ that originates only in pregnancy, and its main function is communication between the mother and the fetus, ensuring healthy development. Thus, this review provides up-to-date information regarding two of the best-documented (epigenetic) mechanisms (DNA methylation and miRNA expression) altered in the human placenta under GDM conditions, as well as potential implications for the offspring.

妊娠期糖尿病(GDM)是妊娠中期或晚期发现的一种妊娠并发症,在妊娠前未表现出明显的葡萄糖耐受不良或糖尿病。2019年,国际糖尿病联合会报告称,15.8%的活产婴儿在妊娠期间受到高血糖的影响,其中83.6%是由于妊娠期糖尿病,8.5%是由于妊娠期首次发现的糖尿病,7.9%是由于妊娠前发现的糖尿病。GDM增加了母亲和婴儿在以后的生活中患慢性疾病的易感性。在GDM条件下,宫内环境变得高血糖,同时也显示出高浓度的脂肪酸和促炎细胞因子,在胎盘中产生形态、结构和分子改变,影响其功能;这些改变可能使婴儿在成年后易患疾病。分子改变包括表观遗传机制,如DNA和RNA甲基化、染色质重塑、组蛋白修饰和非编码RNA (ncRNAs)的表达。胎盘是一个独特的器官,仅在怀孕期间产生,其主要功能是母亲和胎儿之间的沟通,确保健康发育。因此,这篇综述提供了关于GDM条件下人类胎盘中两种最有效的(表观遗传)机制(DNA甲基化和miRNA表达)改变的最新信息,以及对后代的潜在影响。
{"title":"The Placenta as a Target of Epigenetic Alterations in Women with Gestational Diabetes Mellitus and Potential Implications for the Offspring.","authors":"Dennise Lizárraga,&nbsp;Alejandra García-Gasca","doi":"10.3390/epigenomes5020013","DOIUrl":"https://doi.org/10.3390/epigenomes5020013","url":null,"abstract":"<p><p>Gestational diabetes mellitus (GDM) is a pregnancy complication first detected in the second or third trimester in women that did not show evident glucose intolerance or diabetes before gestation. In 2019, the International Diabetes Federation reported that 15.8% of live births were affected by hyperglycemia during pregnancy, of which 83.6% were due to gestational diabetes mellitus, 8.5% were due to diabetes first detected in pregnancy, and 7.9% were due to diabetes detected before pregnancy. GDM increases the susceptibility to developing chronic diseases for both the mother and the baby later in life. Under GDM conditions, the intrauterine environment becomes hyperglycemic, while also showing high concentrations of fatty acids and proinflammatory cytokines, producing morphological, structural, and molecular modifications in the placenta, affecting its function; these alterations may predispose the baby to disease in adult life. Molecular alterations include epigenetic mechanisms such as DNA and RNA methylation, chromatin remodeling, histone modifications, and expression of noncoding RNAs (ncRNAs). The placenta is a unique organ that originates only in pregnancy, and its main function is communication between the mother and the fetus, ensuring healthy development. Thus, this review provides up-to-date information regarding two of the best-documented (epigenetic) mechanisms (DNA methylation and miRNA expression) altered in the human placenta under GDM conditions, as well as potential implications for the offspring.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"5 2","pages":""},"PeriodicalIF":2.5,"publicationDate":"2021-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3390/epigenomes5020013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39650224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
The EpiDiverse Plant Epigenome-Wide Association Studies (EWAS) Pipeline. EpiDiverse植物表观基因组关联研究(EWAS)管道。
IF 2.5 Q3 GENETICS & HEREDITY Pub Date : 2021-05-04 DOI: 10.3390/epigenomes5020012
Sultan Nilay Can, Adam Nunn, Dario Galanti, David Langenberger, Claude Becker, Katharina Volmer, Katrin Heer, Lars Opgenoorth, Noe Fernandez-Pozo, Stefan A Rensing

Bisulfite sequencing is a widely used technique for determining DNA methylation and its relationship with epigenetics, genetics, and environmental parameters. Various techniques were implemented for epigenome-wide association studies (EWAS) to reveal meaningful associations; however, there are only very few plant studies available to date. Here, we developed the EpiDiverse EWAS pipeline and tested it using two plant datasets, from P. abies (Norway spruce) and Q. lobata (valley oak). Hence, we present an EWAS implementation tested for non-model plant species and describe its use.

亚硫酸氢盐测序是一种广泛使用的技术,用于确定DNA甲基化及其与表观遗传学、遗传学和环境参数的关系。采用各种技术进行全表观基因组关联研究(EWAS)以揭示有意义的关联;然而,迄今为止只有很少的植物研究。在这里,我们开发了EpiDiverse EWAS管道,并使用两种植物数据集进行了测试,分别是P. abies(挪威云杉)和Q. lobata(山谷橡树)。因此,我们提出了一个EWAS实现测试非模式植物物种和描述其使用。
{"title":"The EpiDiverse Plant Epigenome-Wide Association Studies (EWAS) Pipeline.","authors":"Sultan Nilay Can,&nbsp;Adam Nunn,&nbsp;Dario Galanti,&nbsp;David Langenberger,&nbsp;Claude Becker,&nbsp;Katharina Volmer,&nbsp;Katrin Heer,&nbsp;Lars Opgenoorth,&nbsp;Noe Fernandez-Pozo,&nbsp;Stefan A Rensing","doi":"10.3390/epigenomes5020012","DOIUrl":"https://doi.org/10.3390/epigenomes5020012","url":null,"abstract":"<p><p>Bisulfite sequencing is a widely used technique for determining DNA methylation and its relationship with epigenetics, genetics, and environmental parameters. Various techniques were implemented for epigenome-wide association studies (EWAS) to reveal meaningful associations; however, there are only very few plant studies available to date. Here, we developed the EpiDiverse EWAS pipeline and tested it using two plant datasets, from <i>P. abies</i> (Norway spruce) and <i>Q. lobata</i> (valley oak). Hence, we present an EWAS implementation tested for non-model plant species and describe its use.</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"5 2","pages":""},"PeriodicalIF":2.5,"publicationDate":"2021-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3390/epigenomes5020012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39650223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Firing up Cold Tumors-Targeting the Epigenetic Machinery to Enhance Cancer Immunotherapy. 激活冷肿瘤--针对表观遗传机制加强癌症免疫疗法。
IF 2.5 Q3 GENETICS & HEREDITY Pub Date : 2021-05-03 DOI: 10.3390/epigenomes5020011
Guan-Ling Lin, Leah H J Tsai, Peter J K Kuppen, Michael W Y Chan

Cancer immunotherapy using monoclonal antibodies targeting immune checkpoint proteins, such as PD-L1 or PD-1 (i [...].

使用针对免疫检查点蛋白(如PD-L1或PD-1)的单克隆抗体进行癌症免疫疗法(即[...])。
{"title":"Firing up Cold Tumors-Targeting the Epigenetic Machinery to Enhance Cancer Immunotherapy.","authors":"Guan-Ling Lin, Leah H J Tsai, Peter J K Kuppen, Michael W Y Chan","doi":"10.3390/epigenomes5020011","DOIUrl":"10.3390/epigenomes5020011","url":null,"abstract":"<p><p>Cancer immunotherapy using monoclonal antibodies targeting immune checkpoint proteins, such as PD-L1 or PD-1 (i [...].</p>","PeriodicalId":55768,"journal":{"name":"Epigenomes","volume":"5 2","pages":""},"PeriodicalIF":2.5,"publicationDate":"2021-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39650221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Epigenomes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1